The scientific research and letter of Nuran Abdullayev, Director of the Institute of Biomedical Engineering of Azerbaijan Technical University (AzTU), Professor, Doctor of Medical Sciences, and Director of the Clinic in the Rhein-Sieg Region of Germany, were published in the journal “New England Journal of Medicine” (NEJM).

In the article, Nuran Abdullayev commented on the differences between two drugs used in the treatment of obesity – “Tirzepatid” (GIP-GLP-1 receptor agonist - “Mounjaro”) and “Semaglutide” (GLP-1 receptor agonist - “Wegovy”) in a scientific context. The professor emphasized that although these studies mainly focus on weight loss and metabolic outcomes, important components such as visceral adiposity, changes in muscle mass, and bone mineral density (BMD) have not yet been sufficiently studied. He proposed, on a scientific basis, the application of modern imaging methods such as MRI-based body composition measurements and DXA+MRI combination for future studies in order to fully assess the effects of these drugs on metabolic health and the skeletal system.

It should be noted that the publication of any article in the "New England Journal of Medicine", one of the most prestigious medical journals in the world, is considered a major event in the medical world and a high scientific achievement for the author. Published since 1812, this journal is considered the most authoritative scientific source in the field of clinical medicine. NEJM, published in the USA, is one of the journals with the highest Impact Factor among all medical publications in the world. A very strict selection process is carried out for the acceptance of articles in the journal. Thus, a very small part of the articles submitted for publication - only 10 percent, especially scientific articles with deep scientific justification and international importance, are published.

The works published in the journal, which has a large readership, are read by doctors, scientists, high-ranking health policymakers and commissions that prepare international clinical protocols around the world. The publication of any article in this journal, which has the potential to influence changes in treatment standards, demonstrates the high scientific and clinical value of that work on a global scale.